spinout
EnPlusOne Biosciences Nabs Exclusive License to RNA Synthesis Technology from Wyss Institute
EnPlusOne Bio has secured a worldwide license to the ezRNA platform developed in the lab of George Church, one of the firm's cofounders.
Light-Seq enables researchers to laser-spot areas of interest in tissue sections for analysis with both imaging and sequencing.
Harvard University, Wyss Institute License Protein Detection Technology to Spear Bio
Spear Bio plans to use the technology to build a protein detection platform and an assay that can measure levels of neutralizing antibodies against SARS-CoV-2.
The firm is commercializing technology to analyze degraded DNA developed by the paleogenomics lab at the University of California, Santa Cruz.
The lead investigators have also spun out a company, Isabl, aiming to make the approach available to the broader community.